Workup and Management of Urinalysis Positive for Blood, Microalbumin, and Protein
Confirm the urinalysis findings with quantitative testing using first morning void urine albumin-to-creatinine ratio (ACR) and protein-to-creatinine ratio (PCR), as reagent strip urinalysis has significant false-positive rates, particularly when blood is present. 1, 2
Initial Confirmatory Testing
The presence of hematuria alongside proteinuria significantly increases the false-positive rate of dipstick urinalysis for protein detection—up to 98% of false-positives occur when confounding factors like ≥3+ blood are present 2. Therefore:
- Obtain quantitative measurements: First morning void urine ACR and PCR are essential to confirm and quantify the degree of proteinuria 1
- Confirm ACR ≥30 mg/g (≥3 mg/mmol) on a random sample with a subsequent first morning void specimen 1
- In children: Obtain both urine PCR and urine ACR from first morning sample 1
Urine Microscopy Evaluation
Perform routine evaluation of urine sediment for erythrocyte morphology, red cell casts, and acanthocytes to distinguish glomerular from non-glomerular hematuria 3. This is critical because:
- Dysmorphic RBCs, red cell casts, or acanthocytes indicate glomerular disease 3, 4
- Eumorphic RBCs suggest non-glomerular sources 5
- The presence of both hematuria and proteinuria together requires further workup and careful monitoring 6
Essential Laboratory Workup
Once glomerular disease is suspected (combined hematuria and proteinuria):
- Serum creatinine with eGFR calculation using CKD-EPI creatinine equation 3
- Serum albumin to assess for nephrotic-range proteinuria 3
- Complete metabolic panel including electrolytes and bicarbonate 3
- Complement levels (C3, C4) for glomerulonephritis evaluation 3
- Serologic testing: ANA, ANCA, anti-GBM antibodies, hepatitis B/C, HIV as clinically indicated 3
- Urine calcium-to-creatinine ratio to evaluate for hypercalciuria 5
Imaging Studies
- Renal and bladder ultrasonography to evaluate for anatomic abnormalities, stones, masses, or hydronephrosis 5
Management Approach
For Confirmed Proteinuria with Hematuria:
Initiate ACE inhibitor or ARB therapy titrated to maximally tolerated dose as first-line treatment for patients with both hypertension and proteinuria 3. Key management principles:
- Target systolic blood pressure <120 mmHg using standardized office measurement in adults 3
- In children: Target 24-hour mean arterial pressure at 50th percentile for age, sex, and height by ambulatory blood pressure monitoring 3
- Proteinuria goal typically <1 g/day (variable by disease process) 3
- In children: PCR <200 mg/g (<20 mg/mmol) or <8 mg/m²/hour in 24-hour urine 3
Critical Caveats for ACE Inhibitor/ARB Use:
- Do NOT start ACEi/ARB in patients with abrupt onset nephrotic syndrome—these drugs can cause acute kidney injury, especially in minimal change disease 3
- Do not stop ACEi/ARB with modest and stable serum creatinine increase (up to 30%) 3
- Stop ACEi/ARB if kidney function continues to worsen or refractory hyperkalemia develops 3
- Monitor labs frequently when on ACEi/ARB therapy 3
Adjunctive Lifestyle Modifications:
- Restrict dietary sodium to <2.0 g/day (<90 mmol/day) 3
- Weight normalization, smoking cessation, regular exercise 3
Indications for Nephrology Referral
Refer to nephrology if:
- Persistent hematuria with concomitant proteinuria 7
- Proteinuria is drug-resistant 7
- Renal biopsy is being considered 7
- Hematuria does not resolve within 2 weeks of onset of glomerulonephritis 4
- Persistent microscopic hematuria requiring specific urine biochemistry testing 4
- Rapidly changing kidney function 3